Andreas Eschbach is the founder and CEO of eschbach, a software company that helps production teams work smarter and enhance collaboration. Within the process industry, the chemical and pharmaceutical ...

Industry 4.0 technologies facilitate a wide variety of innovations in technological transitions, cyber-physical system (CPS) improvement, and commercialization. Industry 4.0's objective is to create ...

The newly designed SLS-20 syringe sampler, along with Chem 20 particle counter, enables offline batch sampling for process chemicals’ research, manufacturing, distribution, and packaging. The SLS-20 ...

TOKYO--(BUSINESS WIRE)--Shin-Etsu Chemical Co., Ltd. (TOKYO: 4063) (Head Office: Tokyo; President: Yasuhiko Saitoh; hereinafter, “Shin-Etsu Chemical”) has developed equipment to manufacture ...

Emerson has introduced DeltaV Edge Environment 2.0, the newest version of its edge technology for delivering OT (operations technology) applications and contextualized control data anywhere in the ...

Process industry software developer eschbach has launched a new batch tracking solution for its Shiftconnector® enterprise manufacturing platform, promoting seamless collaboration between production, ...

Historically, pharmaceutical products have been produced in a traditional ‘batch’ system, in which every operation is executed separately using a defined quantity of materials. In batch manufacturing ...

In batch manufacturing operations, a campaign manager is a database module that acts as a translator between ERP and scheduling software and the batch engine to prevent errors and over-production.

The ISA-88 series of standards, also known as batch process control standards, bring clarity, structure and consistency to batch processing in pharmaceuticals, food and beverage industries, chemicals ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Continuous manufacturing makes monoclonal antibody production faster, cheaper, and greener, say researchers, who predict that industry adoption of the approach will accelerate in response to ...